BIOCIENCIAS: Bª Y CLÍNICA DEL CÁNCER Y MEDIC. TRASLACIONAL
Escuela de doctorado
John Radcliffe Hospital
Oxford, Reino UnidoPublicaciones en colaboración con investigadores/as de John Radcliffe Hospital (9)
2022
-
CD34+CD19−CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies
Blood, Vol. 140, Núm. 1, pp. 38-44
-
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: Final results of the SYNTAX II study
European Heart Journal, Vol. 43, Núm. 13, pp. 1307-1316
2019
-
Impact of post-procedural minimal stent area on 2-year clinical outcomes in the SYNTAX II trial
Catheterization and Cardiovascular Interventions, Vol. 93, Núm. 4, pp. E225-E234
2017
-
Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study
European Heart Journal, Vol. 38, Núm. 42, pp. 3124-3134
2012
-
Guidelines for the use and interpretation of assays for monitoring autophagy
Autophagy, Vol. 8, Núm. 4, pp. 445-544
2004
-
Lenograstim after autologous peripheral blood progenitor cell transplantation: Results of a double-blind, randomized trial
Bone Marrow Transplantation, Vol. 34, Núm. 11, pp. 955-962
2003
2002
-
Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: Identification of a new TFG-ALKXL chimeric gene with transforming activity
American Journal of Pathology, Vol. 160, Núm. 4, pp. 1487-1494
2000
-
Genomic analysis of the vitellogenin locus in rainbow trout (Oncorhynchus mykiss) reveals a complex history of gene amplification and retroposon activity
Molecular and General Genetics, Vol. 263, Núm. 5, pp. 828-837